Clinical Trials Search among the pediatric clinical trials we have open at the Vall d'Hebron Research Institute. Recruitment - Any -YesNo Phase - Any -Phase IPhase IIPhase IIIPhase IV Alphabetic A-Z Alphabetic Z-A Phase Title Sort descending Department Recruitment Phase III 18-month double-blind, randomized, placebo-controlled, multicenter,… General Pediatrics and Specialties No Phase I A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in… General Pediatrics and Specialties Yes Phase I A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in… General Pediatrics and Specialties No Phase I A Multicenter, Open-label, Interventional Phase I Trial to Determine the… Pediatric Oncohematology No Phase III A Multi-center, Randomized, Double-blind, Placebo-controlled Trial… General Pediatrics and Specialties Yes Phase II A phase 2, multicenter, open-label study to assess appropriate dosing… Pediatric Oncohematology Yes Phase II A Phase 2 Open-Label Study of Continuation Treatment With Combination… General Pediatrics and Specialties Yes Phase III A phase 3, randomized, double-blind, placebo-controlled, parallel-arm… General Pediatrics and Specialties Yes Phase II A phase II, randomized, open-label study to assess the efficacy, safety,… Pediatric Oncohematology Yes Phase II A Phase I/II study of Brigatinib in pediatric and young adult patients… Pediatric Oncohematology Yes Phase I A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other… Pediatric Oncohematology Yes Phase II A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in… Pediatric Oncohematology Yes Phase II A single-arm, multi-centre trial to evaluate efficacy and safety of… Pediatric Nephrology No Phase I A SINGLE-ARM, OPEN-LABEL, MULTI-CENTRE, PHASE IB STUDY EVALUATING THE… Pediatric Oncohematology Yes Phase III A study evaluating the safety and efficacy of once-weekly dosing of… General Pediatrics and Specialties Yes Phase III An open label complex clinical trial in newly diagnosed pediatric de… Pediatric Oncohematology Yes Phase III An Open-Label Extension Study of EryDex in Patients with Ataxia… General Pediatrics and Specialties Yes Phase III An Open-Label Extension to Investigate the Long-Term Safety, Tolerability, and… General Pediatrics and Specialties Yes Phase II An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of… Pediatric Nephrology No Phase II An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and… General Pediatrics and Specialties No Phase I Bayer 20810 - Estudio en fase I/II del inhibidor de la… Pediatric Oncohematology Yes Phase III Ensayo aleatorizado de fase 3 de fludarabina/citarabina/… Pediatric Oncohematology No Phase II Ensayo clínico de fase II, doble ciego, aleatorizado, de… General Pediatrics and Specialties Yes Phase II Ensayo Clínico de transferencia génica fase I/II con scAAV9.U1a.hSGSH para… General Pediatrics and Specialties Yes Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next page Next › Last page Last »
